Cargando…
Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays
Rapid tests for SARS-COV-2 infection are important tools for pandemic control, but current rapid tests are based on proprietary designs and reagents. We report clinical validation results of an open-access lateral flow assay (OA-LFA) design using commercially available materials and reagents, along...
Autores principales: | Bachman, Christine M., Grant, Benjamin D., Anderson, Caitlin E., Alonzo, Luis F., Garing, Spencer, Byrnes, Sam A., Rivera, Rafael, Burkot, Stephen, Ball, Alexey, Stafford, James W., Wang, Wenbo, Banik, Dipayan, Keller, Matthew D., Cate, David M., Nichols, Kevin P., Weigl, Bernhard H., Dewan, Puneet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370603/ https://www.ncbi.nlm.nih.gov/pubmed/34403456 http://dx.doi.org/10.1371/journal.pone.0256352 |
Ejemplares similares
-
A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay
por: Grant, Benjamin D., et al.
Publicado: (2021) -
Antibody Screening Results for Anti-Nucleocapsid Antibodies
Toward the Development of a Lateral Flow Assay to Detect SARS-CoV-2
Nucleocapsid Protein
por: Cate, David M., et al.
Publicado: (2021) -
A Novel Malaria Lateral Flow Assay for Detecting Plasmodium falciparum Lactate Dehydrogenase in Busia, Uganda
por: Bachman, Christine M., et al.
Publicado: (2022) -
A review of commercially available thrombin generation assays
por: Kintigh, Jeremy, et al.
Publicado: (2017) -
Rapid, sensitive, and low-cost detection of Escherichia coli bacteria in contaminated water samples using a phage-based assay
por: Alonzo, Luis F., et al.
Publicado: (2022)